Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
3.07M
-
Shares change
-
+20.9K
-
Total reported value, excl. options
-
$9.66M
-
Value change
-
+$59.8K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$3.14
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2016
15 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2016.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.07M shares
of 108M outstanding shares and own 2.85% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1.62M shares), Southpoint Capital Advisors LP (800K shares), Knoll Capital Management, LP (462K shares), GEODE CAPITAL MANAGEMENT, LLC (63.7K shares), MORGAN STANLEY (51.9K shares), GOLDMAN SACHS GROUP INC (19.4K shares), GARRISON BRADFORD & ASSOCIATES INC (15.5K shares), National Asset Management, Inc. (12K shares), Bank of New York Mellon Corp (10.3K shares), and UBS Group AG (3.6K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.